Treatment for Lung Cancer
Dear Southern Health and Social Care Trust (Northern Ireland),
The following question is being requested on behalf of Novartis. The purpose of these questions is to understand the variability of treatment within your trust and in context to
the rest of the country.
Q1. In the past 3 months (or the latest 3 months data you have available), how many metastatic non-small cell lung cancer (NSCLC) patients were treated with any of the following:
• Afatinib
• Alectinib
• Atezolizumab monotherapy
• Atezolizumab in combination
• Bevacizumab
• Brigatinib
• Capmatenib
• Ceritinib
• Crizotinib
• Dacomitinib
• Dabrafenib with Trametinib
• Docetaxel monotherapy
• Durvalumab
• Erlotinib
• Gefitinib
• Gemcitabine
• Nintedanib with Docetaxel
• Nivolumab
• Osimertinib
• Paclitaxel
• Pembrolizumab monotherapy
• Pembrolizumab in combination
• Pemetrexed with Carboplatin/Cisplatin
• Tepotinib
• Vinorelbine with Cisplatin/Carboplatin
• Any other SACT
• Palliative care only
Thank you for taking the time to answer this question and I look forward to hearing from you.
Yours faithfully,
Ben Holdsworth
Thank you for your email.
We acknowledge receipt of your request.
You will be aware of the significant pressures on our health and social
care services during the current surge of the Covid-19 pandemic. During
this time we have been asking our staff to prioritise their professional
caring duties and to support front line health and social care services in
responding to the emergency. This has understandably had an impact on
other duties within their role such as responding to legislative
requirements under FOI and the processing of Subject Access Requests.
We assure you that your request will be logged and processed, and we will
do our utmost to respond as quickly as possible.
Yours faithfully
Information Governance Team
Dear Mr Holdsworth,
Please find attached response in respect of your recent FOI request to the Southern Health and Social Care Trust.
Kind regards
Gail Fegan
Information Governance Officer
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now